Related Experiment Video
Updated: Aug 7, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Development of ligands for the peripheral benzodiazepine receptor
Michelle L James1, Silvia Selleri, Michael Kassiou
1Department of Pharmacology, University of Sydney, NSW 2006, Australia.
Abstract:
The peripheral benzodiazepine receptor (PBR) initially characterised as a high affinity binding site for diazepam, is densely distributed in most peripheral organs whilst only moderately expressed in the healthy brain. The predominant cell type expressing the PBR at regions of central nervous system (CNS) pathology are activated microglial cells. Under neuroinflammatory conditions there is an over-expression of PBR binding sites indicating that measurements of PBR density can act as a useful index of brain disease activity. The PBR is now considered a significant therapeutic and diagnostic target which has provided the impetus for PBR ligand development. There are several classes of PBR ligands available including benzodiazepines (Ro5-4864), isoquinoline carboxamides (PK 11195), indoleacetamides (FGIN-1-27), phenoxyphenyl-acetamides (DAA1106) and pyrazolopyrimidines (DPA-713). Subsequent conformationally restrained isoquinoline and indoleacetamide analogues have been synthesised in an attempt to yield PBR ligands with superior affinity and brain kinetics. Even though the PBR has been linked to a number of biochemical processes, including cell proliferation, apoptosis, steroidogenesis, porphyrin transport and immunomodulation, its exact physiological role is yet to be deciphered. Selective PBR ligands with favourable in vivo binding properties and kinetics is required to gain a more complete understanding on the normal functioning of the PBR and the chemical pathways underlying several pathological conditions. Novel PBR ligands with unique binding properties and functional activity may also generate information on the localisation of the PBR and the possibility of PBR subtypes. This review highlights the main classes of PBR ligands to date. In addition the biological activity and therapeutic potential of certain PBR ligands is discussed.
Insights
Peripheral benzodiazepine receptors (PBR) are key indicators of brain disease activity. Developing selective PBR ligands is crucial for understanding neuroinflammation and developing new diagnostics and therapeutics.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Peripheral benzodiazepine receptor (PBR) is highly expressed in peripheral organs and moderately in the healthy brain.
- Activated microglial cells are the primary PBR expressers in CNS pathology.
- PBR over-expression during neuroinflammation indicates its potential as a brain disease activity index.
Purpose of the Study:
- To review current classes of PBR ligands.
- To discuss the biological activity and therapeutic potential of PBR ligands.
- To highlight the need for selective PBR ligands for further research.
Main Methods:
- Review of existing literature on PBR ligands.
- Analysis of different classes of PBR ligands including benzodiazepines, isoquinoline carboxamides, indoleacetamides, phenoxyphenyl-acetamides, and pyrazolopyrimidines.
- Discussion of synthesized analogues for improved affinity and kinetics.
Main Results:
- Several classes of PBR ligands have been developed, including benzodiazepines, isoquinoline carboxamides, indoleacetamides, phenoxyphenyl-acetamides, and pyrazolopyrimidines.
- Conformationally restrained analogues show promise for enhanced affinity and brain kinetics.
- PBR is implicated in cell proliferation, apoptosis, steroidogenesis, porphyrin transport, and immunomodulation, though its precise physiological role remains unclear.
Conclusions:
- PBR is a significant target for therapeutic and diagnostic development in CNS pathology.
- Selective PBR ligands are essential for elucidating PBR's physiological role and underlying pathological pathways.
- Further research with novel PBR ligands may reveal PBR subtypes and precise localization.
More Related Videos
07:51Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
Published on: November 14, 2014
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
GPCR Desensitization
Anxiolytic Drugs: Benzodiazepines and Buspirone
G-protein Coupled Receptors